Study suggests cat owners should increase the duration of flea and tick treatment

Flea and tick control is a crucial component in preventive care and companion animal practice.

A retrospective study of owners purchasing feline flea and tick products was conducted and compared them based on the annual doses purchased by cat owners. Records were analyzed from a commercial database obtained from a veterinary practice management software.

Results showed that cat owners purchased an average of 1.5 doses of fluralaner per year, which provides about 4.2 months of treatment. The combination of fipronil, s-methoprene, and pyriproxyfen was purchased by pet owners for 3.6 months, while the combination imidacloprid and pyriproxyfen was purchased for 2.8 months. Feline owners who purchase fluralaner every year reported a longer duration of coverage than feline owners purchasing the combination of fipronil, s-methoprene and pyriproxyfen or imidacloprid/pyriproxyfen.

Feline owners that acquired a flea and tick treatment with a 12-week redosing interval protected their cats for an extended period yearly compared to those who purchased a monthly treatment. All these data obtained suggest that owners should increase the duration of flea and tick control on their cats.

To read more click on the link below:

Adherence to veterinary recommendations for ectoparasiticides purchased by cat owners in the USA

Previous
Previous

Livestock workers, including food animal veterinarians, face high MRSA risk

Next
Next

Rumen additive and controlled energy benefit dairy cows during dry period